ENCOMPASS HEALTH CORP (EHC) Stock Analyst Earnings Estimates
NYSE:EHC - New York Stock Exchange, Inc. - US29261A1007 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.015B 12.58% | 4.349B 8.31% | 4.801B 10.41% | 5.403B 12.53% | 5.896B 9.12% | 6.404B 8.62% | N/A | N/A | |
| EBITDA YoY % growth | 916M 18.44% | 873.8M -4.61% | 1.006B 15.09% | 1.094B 8.78% | 1.192B 8.96% | 1.296B 8.72% | N/A | N/A | |
| EBIT YoY % growth | 659.4M 24.32% | 630.2M -4.43% | 731.8M 16.12% | 824.41M 12.66% | 902.52M 9.47% | 980.18M 8.60% | N/A | N/A | |
| Operating Margin | 16.42% | 14.49% | 15.24% | 15.26% | 15.31% | 15.31% | N/A | N/A | |
| EPS YoY % growth | 4.22 46.02% | 3.41 -19.19% | 3.64 6.74% | 4.33 18.91% | 4.82 11.38% | 5.35 11.04% | 5.34 -0.19% | 5.63 5.29% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.04 9.05% | 1.21 8.17% | 1.21 8.84% | 1.19 15.25% | 1.18 14.26% | 1.33 9.51% | 1.31 8.11% | 1.26 5.72% | 1.30 9.47% |
| Revenue Q2Q % growth | 1.395B 11.89% | 1.449B 10.11% | 1.43B 9.90% | 1.483B 9.77% | 1.515B 8.60% | 1.572B 8.49% | 1.546B 8.11% | 1.596B 7.62% | 1.635B 7.92% |
| EBITDA Q2Q % growth | 273.77M -40.97% | 294.66M 6.07% | 299.18M -16.62% | 298.4M -30.72% | 301.97M 10.30% | 315.54M 7.09% | 318.55M 6.47% | 318.8M 6.84% | 328.83M 8.89% |
| EBIT Q2Q % growth | 202.67M 6.72% | 223M 7.47% | 225.67M 4.67% | 221.6M 5.98% | 224.22M 10.63% | 232.92M 4.45% | 225.65M -0.01% | 233.9M 5.55% | 249.84M 11.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.03 19.77% | 0.95 | 0.08 | 8.15% |
| Q2 2024 Q2Q % growth | 1.11 16.84% | 1.02 | 0.09 | 8.41% |
| Q1 2024 Q2Q % growth | 1.12 27.27% | 0.95 | 0.17 | 18.50% |
| Q4 2023 Q2Q % growth | 0.95 7.95% | 0.82 | 0.13 | 15.27% |
| Q3 2023 Q2Q % growth | 0.86 28.36% | 0.78 | 0.08 | 10.73% |
| Q2 2023 Q2Q % growth | 0.95 6.74% | 0.75 | 0.20 | 26.24% |
| Q1 2023 Q2Q % growth | 0.88 -9.28% | 0.71 | 0.17 | 23.91% |
| Q4 2022 Q2Q % growth | 0.88 -9.28% | 0.84 | 0.04 | 4.80% |
| Q3 2022 Q2Q % growth | 0.67 -34.95% | 0.64 | 0.03 | 3.96% |
| Q2 2022 Q2Q % growth | 0.89 -23.93% | 0.98 | -0.09 | -8.88% |
| Q1 2022 Q2Q % growth | 0.97 -7.62% | 0.93 | 0.04 | 4.69% |
| Q4 2021 Q2Q % growth | 0.97 4.30% | 1.06 | -0.09 | -8.40% |
| Q3 2021 Q2Q % growth | 1.03 32.05% | 1.07 | -0.04 | -3.63% |
| Q2 2021 Q2Q % growth | 1.17 277.42% | 0.98 | 0.19 | 19.03% |
| Q1 2021 Q2Q % growth | 1.05 20.69% | 0.83 | 0.22 | 26.53% |
| Q4 2020 Q2Q % growth | 0.93 9.41% | 0.86 | 0.07 | 7.72% |
| Q3 2020 Q2Q % growth | 0.78 -16.13% | 0.75 | 0.03 | 3.90% |
| Q2 2020 Q2Q % growth | 0.31 -71.30% | 0.39 | -0.08 | -20.41% |
| Q1 2020 Q2Q % growth | 0.87 -16.35% | 0.86 | 0.01 | 0.97% |
| Q4 2019 Q2Q % growth | 0.85 | 0.85 | 0.00 | -0.35% |
| Q3 2019 Q2Q % growth | 0.93 | 0.90 | 0.03 | 3.41% |
| Q2 2019 Q2Q % growth | 1.08 | 0.98 | 0.10 | 9.79% |
| Q1 2019 Q2Q % growth | 1.04 | 0.90 | 0.14 | 16.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.351B 11.94% | 1.341B | 10M | 0.75% |
| Q2 2024 Q2Q % growth | 1.301B 9.61% | 1.318B | -16.8M | -1.27% |
| Q1 2024 Q2Q % growth | 1.316B 13.41% | 1.286B | 30M | 2.33% |
| Q4 2023 Q2Q % growth | 1.247B 9.63% | 1.249B | -2.2M | -0.18% |
| Q3 2023 Q2Q % growth | 1.207B 10.78% | 1.206B | 900K | 0.07% |
| Q2 2023 Q2Q % growth | 1.187B 11.73% | 1.172B | 15.1M | 1.29% |
| Q1 2023 Q2Q % growth | 1.16B 9.54% | 1.156B | 4.4M | 0.38% |
| Q4 2022 Q2Q % growth | 1.137B 9.09% | 1.132B | 5.3M | 0.47% |
| Q3 2022 Q2Q % growth | 1.09B 7.79% | 1.075B | 14.5M | 1.35% |
| Q2 2022 Q2Q % growth | 1.063B 45.31% | 1.357B | -294.5M | -21.70% |
| Q1 2022 Q2Q % growth | 1.059B -13.91% | 1.337B | -277.7M | -20.77% |
| Q4 2021 Q2Q % growth | 1.043B 664.86% | 1.32B | -277.5M | -21.02% |
| Q3 2021 Q2Q % growth | 1.011B -13.89% | 1.327B | -316.2M | -23.83% |
| Q2 2021 Q2Q % growth | 731.2M -31.92% | 1.277B | -545.8M | -42.74% |
| Q1 2021 Q2Q % growth | 1.23B 4.09% | 1.243B | -12.6M | -1.01% |
| Q4 2020 Q2Q % growth | 136.3M -88.49% | 1.217B | -1.081B | -88.80% |
| Q3 2020 Q2Q % growth | 1.174B 1.06% | 1.192B | -18.1M | -1.52% |
| Q2 2020 Q2Q % growth | 1.074B -5.37% | 1.066B | 8.1M | 0.76% |
| Q1 2020 Q2Q % growth | 1.182B 5.16% | 1.212B | -30M | -2.48% |
| Q4 2019 Q2Q % growth | 1.184B | 1.19B | -5.6M | -0.47% |
| Q3 2019 Q2Q % growth | 1.162B | 1.163B | -1.4M | -0.12% |
| Q2 2019 Q2Q % growth | 1.135B | 1.146B | -11M | -0.96% |
| Q1 2019 Q2Q % growth | 1.124B | 1.127B | -3M | -0.27% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.01% | 0% | 2.48% |
| Revenue | 0% | 1.53% | 0% | 0.63% |